StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

XORTX Therapeutics's enterprise value was $97.54K on Nov 11, 2026, against $355.99K a year earlier. Over the last 5 years it ranged from $97.54K to $1.39B, with a median of $17.78M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$97.54K-68.4%
2025Dec 31, 2025$308.56K-97.2%
2024Dec 31, 2024$11.19M-34.5%
2023Dec 29, 2023$17.09M-97.0%
2022Dec 30, 2022$570.25M–

More XORTX Therapeutics figures

See a number that looks wrong?